so, i m sure it will have news of that in the next hour. so, i m sure it will have news of that in the next hour. that s all the sport for now. a new malaria vaccine has proved to be 77% effective in early trials. malaria kills more than 400,000 people a year in sub saharan africa, many of them children. the vaccine has been developed by the team behind the oxford astrazeneca jab and the effectiveness is far higherfigure than for any existing treatment. there will be larger scale testing. prof adrian hill of the university of oxford said he believed the vaccine had the potential to cut the death toll dramatically. this is very exciting. it s a very difficult disease to vaccinate against. it s caused by a parasite. we have no vaccines at all against any parasitic diseases. technically, this has been a long time coming. people have been trying to make malaria vaccines for many decades. so, this one really is part
seen it provides good protection against the kent variant. but in the uk, the numbers of variants from india and south africa and so on are actually very small. even though we studied 370,000 people, we haven t seen enough cases to answer those questions, so that is something we will definitely be looking at carefully over the next six months. it comes back to the point that actually we have to do everything we can to reduce transmission, and that includes vaccination but also includes vaccination but also includes facemasks and social distancing, washing hands and all the other things that we know work. really interesting to talk to you today, professor sarah walker. hopefully we can talk to you again as you continue to look at the data. a new malaria vaccine has been shown to be very effective in early trials. the vaccine has been developed by the team behind the
oxford astrazeneca jack and the 0xford astrazeneca jack and the effectiveness is a far higher figure than for any existing treatment. there will be some larger scale testing taken place. more than 100 people. more than 100 people are reported to have been hurt in clashes in eastjerusalem during rival demonstrations by palestinians and a far rightjewish group. there were confrontations between the two sides, and between palestinian protesters and the israeli police, who were trying to keep the groups apart. tom bateman is injerusalem. these tensions have been bubbling for nights now was not this evening it feels more angry, it is more organised, and this seems like a culmination.
a new malaria vaccine has proved to be 77 per cent effective in early trials. malaria kills more than 400,000 people a year in sub saharan africa, many of them children. the vaccine has been developed by the team behind the oxford astrazeneca jab and the effectiveness is far higherfigure than for any existing treatment. there will be larger scale testing. james whiting is from the charity malaria no more uk. you must be delighted given the massive toll it takes on other parts of the world. irate massive toll it takes on other parts of the world- of the world. we think this is a disease that of the world. we think this is a disease that has of the world. we think this is a disease that has killed - of the world. we think this is a disease that has killed more i of the world. we think this is a - disease that has killed more people than anything else in human history. it has been with us since the dinosaurs. our generation is not only reduced it massively in the last 20 years but is
is far higherfigure than for any existing treatment. there will be larger scale testing. there will of course have to be large scale testing. the lead researcher is professor adrian hill who is director of thejenner institute, where the where the oxford astrazeneca covid vaccine was developed. this is a remarkable result. why do you think it has been so successful? 77% effective. yes, this is very exciting. it is a very difficult disease to vaccinate against. it is caused by a parasite. we have no vaccines at all against any parasitic disease, so technically this has been a long time coming. people have been trained to make malaria vaccines for many decades, so this one really is part of a major collaboration between ourselves at the university in oxford, a fantastic manufacturer,